Absci Insider Buying Signals Confidence in Future Growth and RSU Grants
Absci insider Bedrick Todd’s 15,000‑RSU grant shows management’s confidence in the synthetic‑biology platform’s potential, hinting at upside amid clinical and regulatory milestones.
4 minutes to read